Why was this startup created?

Imagine that you need an urgent surgery, but you’re told you have to wait for 1 to 3 weeks. Could you wait that long? This problem occurs because pathologists, whose job it is to make the final decision before patients can be cleared for an operation, are lacking. They are not working in most hospitals. Medmain’s founder, Osamu Iizuka, is now a medical student. At one point in his life, he was told he needed to wait 3 weeks before being treated for a kidney issue. That incident gave him the idea to found Medmain. 

Please describe your product or service.

This startup is centered around the development of pathological diagnostic software. A pathologist is a doctor who diagnoses the presence or absence of diseases, such as cancer, by observing the tissues and cells of each patient.

Japan, in particular, has a shortage of chronic pathologists. In order to undergo surgery, patients first must receive a pathological diagnosis at the hospital. It can take a long time for results of these diagnoses to be complete, and even in the best case scenario, this wait can cause the patient a lot of mental stress.

Our current product that is in development allows us to perform rapid pathological diagnoses by using pathology images studied by deep learning. We are developing this product in conjunction with the Kyushu University School of Medicine and Kyushu University Hospital. These collaborations give us access to a large amount of image data. Also as part of the development, we are using a supercomputer system with the top computing power in Japan.

What is your company's vision?

Pioneering the new age of medicine through AI.

What are your plans or goals for expanding your business over the next year?

We are planning to hire engineers and designers in April of 2018.

Why are you joining this app?

We are joining to help achieve our aim of global expansion for our product.